Cite
Brar G, Farhat NA, Sukhina A, et al. Deletion of immune evasion genes provides an effective vaccine design for tumor-associated herpesviruses. NPJ Vaccines. 2020;5(1):102doi: 10.1038/s41541-020-00251-x.
Brar, G., Farhat, N. A., Sukhina, A., Lam, A. K., Kim, Y. H., Hsu, T., Tong, L., Lin, W. W., Ware, C. F., Blackman, M. A., Sun, R., & Wu, T. T. (2020). Deletion of immune evasion genes provides an effective vaccine design for tumor-associated herpesviruses. NPJ vaccines, 5(1), 102. https://doi.org/10.1038/s41541-020-00251-x
Brar, Gurpreet, et al. "Deletion of immune evasion genes provides an effective vaccine design for tumor-associated herpesviruses." NPJ vaccines vol. 5,1 (2020): 102. doi: https://doi.org/10.1038/s41541-020-00251-x
Brar G, Farhat NA, Sukhina A, Lam AK, Kim YH, Hsu T, Tong L, Lin WW, Ware CF, Blackman MA, Sun R, Wu TT. Deletion of immune evasion genes provides an effective vaccine design for tumor-associated herpesviruses. NPJ Vaccines. 2020 Nov 05;5(1):102. doi: 10.1038/s41541-020-00251-x. PMID: 33298958; PMCID: PMC7644650.
Copy
Download .nbib